🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pei Ling Chia

Agency for Science, Technology and Research

ORCID: 0000-0002-1656-4770

Also affiliated with Institute of Molecular and Cell Biology

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer”.

Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer

Nature Cancer(2022)10.1038/s43018-022-00489-5

N/A

2.2DataRank · unranked

77 citations

Qingfei Pan, Codruța Chiuzan, Maika Onishi, Yuxin Li, Haiyan Tan +21 more

Network-based assessment of HDAC6 activity is highly predictive of pre-clinical and clinical responses to the HDAC6 inhibitor ricolinostat

medRxiv(2020)10.1101/2020.04.23.20066928

N/A

0DataRank · unranked

5 citations

Qingfei Pan, Cody Chiuzan, Maika Onishi, Mariano J. Alvarez, Erin Honan +17 more

Pseudo-temporal dynamics of chemoresistant triple negative breast cancer cells reveal EGFR/HER2 inhibition as synthetic lethal during mid-neoadjuvant chemotherapy

iScience(2023)10.1016/j.isci.2023.106064

N/A

0DataRank · unranked

5 citations

Pei Ling Chia, Xianxiao Zhou, Martin J. Walsh, José Silva, Bin Zhang +1 more